Aarey Drugs Pharmaceuticals Stock Fundamentals
| AAREYDRUGS | 55.00 1.29 2.29% |
Aarey Drugs Pharmaceuticals fundamentals help investors to digest information that contributes to Aarey Drugs' financial success or failures. It also enables traders to predict the movement of Aarey Stock. The fundamental analysis module provides a way to measure Aarey Drugs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aarey Drugs stock.
At this time, Aarey Drugs' Selling General Administrative is relatively stable compared to the past year. As of 11/26/2024, EBIT is likely to grow to about 44.2 M, while Selling And Marketing Expenses is likely to drop slightly above 1.6 M. Aarey | Select Account or Indicator |
Aarey Drugs Pharmaceuticals Company Current Valuation Analysis
Aarey Drugs' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Aarey Drugs Current Valuation | 1.94 B |
Most of Aarey Drugs' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aarey Drugs Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Aarey Drugs Pharmaceuticals has a Current Valuation of 1.94 B. This is 86.52% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all India stocks is 88.35% higher than that of the company.
Aarey Drugs Pharmace Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Aarey Drugs's current stock value. Our valuation model uses many indicators to compare Aarey Drugs value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aarey Drugs competition to find correlations between indicators driving Aarey Drugs's intrinsic value. More Info.Aarey Drugs Pharmaceuticals is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.16 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Aarey Drugs Pharmaceuticals is roughly 6.45 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aarey Drugs' earnings, one of the primary drivers of an investment's value.Aarey Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aarey Drugs' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aarey Drugs could also be used in its relative valuation, which is a method of valuing Aarey Drugs by comparing valuation metrics of similar companies.Aarey Drugs is currently under evaluation in current valuation category among its peers.
Aarey Fundamentals
| Return On Equity | 0.0374 | ||||
| Return On Asset | 0.0058 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 1.94 B | ||||
| Shares Outstanding | 28.35 M | ||||
| Shares Owned By Insiders | 51.13 % | ||||
| Shares Owned By Institutions | 2.62 % | ||||
| Price To Book | 1.15 X | ||||
| Price To Sales | 0.33 X | ||||
| Revenue | 3.96 B | ||||
| Gross Profit | 207.6 M | ||||
| EBITDA | 45.16 M | ||||
| Net Income | 46.84 M | ||||
| Total Debt | 313.52 M | ||||
| Book Value Per Share | 47.33 X | ||||
| Cash Flow From Operations | (25.8 M) | ||||
| Earnings Per Share | 2.26 X | ||||
| Beta | 0.92 | ||||
| Market Capitalization | 1.54 B | ||||
| Total Asset | 3.03 B | ||||
| Retained Earnings | 531.26 M | ||||
| Working Capital | 1.14 B | ||||
| Net Asset | 3.03 B |
About Aarey Drugs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aarey Drugs Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aarey Drugs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aarey Drugs Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 13.3 M | 12.6 M | |
| Total Revenue | 4 B | 2.7 B | |
| Cost Of Revenue | 3.8 B | 2.6 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Aarey Stock Analysis
When running Aarey Drugs' price analysis, check to measure Aarey Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarey Drugs is operating at the current time. Most of Aarey Drugs' value examination focuses on studying past and present price action to predict the probability of Aarey Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarey Drugs' price. Additionally, you may evaluate how the addition of Aarey Drugs to your portfolios can decrease your overall portfolio volatility.